Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...

Sesen today announced the launch of TrialS, a next generation regulatory translation validation platform designed to help ...

Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...

DX Medical (ASX:4DX) has seen its price jump back to $2.20/sh, up +10%, as its next-gen lung imaging scan tech gets picked up ...

Founded in 2009, Tides has evolved from a distributor of birth-tissue products into a biotechnology platform focused on ...

This is a new position for Foresite Capital Management IV, LLC, representing 13.8% of reportable assets under management as ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for ...

Thor Medical ASA, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, and ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

The Symbol of National Quality (SNQ), initiated by Taiwan’s Institute for Biotechnology and Medicine Industry (IBMI), has partnered with the International Consortium for Health Outcomes Measurement ...

Biopharma quality control is being revolutionized by advanced analytics and digital transformation through a synergy that ...